Table 3 |
||||||
|
Late bladder/rectal toxicity using RTOG scoring after prostate treatment using the 35 and 36.25 Gy doses for those patients with a minimum 12 month follow-up |
||||||
|
RTOG grade % (number) of patients |
||||||
|
|
||||||
|
Total Dose |
0 |
I |
II |
III |
IV |
|
|
|
||||||
|
Late Urinary |
35 Gy |
94% (45) |
4% (2) |
2% (1) |
- |
- |
|
|
||||||
|
36.25 Gy |
88.9% (183) |
4.8% (10) |
5.8% (12) |
0.5% (1) |
- |
|
|
|
||||||
|
Late Rectal |
35 Gy |
95.8% (46) |
4.2% (2) |
- |
- |
- |
|
|
||||||
|
36.25 Gy |
91.8% (189) |
5.3% (11) |
2.9% (6) |
- |
- |
|
|
|
||||||
|
Katz et al. BMC Urology 2010 10:1 doi:10.1186/1471-2490-10-1 |
||||||
